RNU6-313P

Across TCGA pan-cancer cohorts, RNU6-313P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-313P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU6-313P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-313P expression acts as an unfavorable survival marker, although some lineages such as UCS and LAML show a favorable association.

CHOL, SKCM, and LUAD are the cancer types where RNU6-313P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.675	<.001	72	view →
SKCM	DFS	Tertile	All	0.493	0.779	<.001	69	view →
LUAD	OS	Tertile	II,III,IV	0.247	0.567	.002	54	view →
LUSC	OS	Tertile	III,IV	0.154	0.660	.009	48	view →
READ	DFS	Tertile	III,IV	0.027	0.761	<.001	36	view →
COAD	DFS	Tertile	II,III,IV	0.175	0.468	.012	24	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
ACC	OS	Tertile	III,IV	0.295	0.736	.002	12	view →
LAML	DFS	Quartile	All	0.804	0.442	.006	12	view →
GBM	OS	Tertile	All	0.188	0.288	.032	9	view →
KIRC	DFS	Quartile	IV	0.243	0.501	.047	6	view →
ESCA	OS	Tertile	IV	0.743	0.393	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-313P–CHOL (OS)

Open the CHOL breakdown →